Stock NVRO NEVRO CORP.
Add to a list
To use this feature you must be a member
Log inSign up

Press Releases Nevro Corp.

Equities

NVRO

US64157F1030

Delayed Nyse
Other stock markets
 03:48:00 2024-05-23 pm EDT 		5-day change 1st Jan Change
9.33 USD -4.89% Intraday chart for Nevro Corp. -16.29% -56.55%
May. 22 Citigroup Downgrades Nevro to Sell From Neutral, Adjusts Price Target to $9 From $13.50 MT
May. 14 Transcript : Nevro Corp. Presents at Bank of America Health Care Conference 2024, May-14-2024 09:20 AM

Press Releases

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Nevro to Present at BofA Securities 2024 Healthcare Conference
PR
Nevro : First Quarter 2024 Earnings Presentation
PU
Nevro: Q1 Earnings Snapshot
AQ
Nevro Reports First-Quarter 2024 Financial Results
PR
Nevro to Report First-Quarter 2024 Financial Results and Host Earnings Conference Call on May 7, 2024
PR
Non-Opioid Revolution: Beacons of Hope in Opioid Crisis and a $50 Million Spin-Off
AQ
Nevro Receives FDA 510(k) Clearance to Use SI Fixation System Without Need to Include Lateral Screw
PR
Nevro: Q4 Earnings Snapshot
AQ
Nevro Enters Into Cooperation Agreement With Engaged Capital
PR
Nevro Reports Fourth-Quarter and Full-Year 2023 Financial Results
PR
Nevro to Report Fourth-Quarter and Full-Year 2023 Financial Results and Host Conference Call on February 21, 2024
PR
Top 4 Spinal Injury Stocks for 2024 Watchlist (NRX.V, NVRO, SYK, BSX)
AQ
Top 4 Spinal Injury Stocks for 2024 (NRX.V, NVRO, SYK, BSX)
AQ
Nevro Announces Positive Coverage Update from Carelon Healthcare for the Treatment of Painful Diabetic Neuropathy
AQ
Nevro Announces Preliminary Fourth-Quarter and Full-Year 2023 Revenue Results
PR
Nevro to Present at 42nd Annual J.P. Morgan Healthcare Conference
PR
Nevro Announces Acquisition of Vyrsa™ Technologies
PR
Nevro Delivers Long-Term Relief with High-Frequency Spinal Cord Stimulation, 24-Month Data Demonstrates Profound Improvements for Non-Surgical Refractory Back Pain
AQ
Nevro Delivers Long-Term Relief with High-Frequency Spinal Cord Stimulation: 24-Month Data Demonstrates Profound Improvements for Non-Surgical Refractory Back Pain
PR
Nevro: Q3 Earnings Snapshot
AQ
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. NVRO Stock
  4. News Nevro Corp.
  5. Press Releases